RITHMI THE SMART MONITOR THAT TAKES CARE OF YOUR HEART
Arrhythmia Algorithm S.L. (https://rithmi.com) is a privately held company with the mission to support people to take care of
their heart and prevent health problems as the stroke. Our aim is to revolutionize the way Auricular fib...
ver más
ARRHYTHMIA ALGORITHM
. creación y puesta en marcha en el ámbito de internet de aplicaciones móviles, de apps y webs. aplicaciones y desarrollo de wearables de de...
TRL
7-8
| 92K€
Fecha límite participación
Sin fecha límite de participación.
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Información proyecto Rithmi
Duración del proyecto: 4 meses
Fecha Inicio: 2018-11-19
Fecha Fin: 2019-03-31
Líder del proyecto
ARRHYTHMIA ALGORITHM
. creación y puesta en marcha en el ámbito de internet de aplicaciones móviles, de apps y webs. aplicaciones y desarrollo de wearables de de...
TRL
7-8
| 92K€
Presupuesto del proyecto
71K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Arrhythmia Algorithm S.L. (https://rithmi.com) is a privately held company with the mission to support people to take care of
their heart and prevent health problems as the stroke. Our aim is to revolutionize the way Auricular fibrillation is diagnosed
through a comfortable, compliant and innovative method. After successfully piloting the prototype version of RITHMI
technology, the team can confirm the capability of its breakthrough product to open new markets in Europe with the potential
for rapid growth. Rithmi is a pioneer in arrhythmia detection technologies and the leading company in Computational
Predictive Care™. By pursuing the present feasibility study, RITHMI’s management team aims to improve its understanding
of international market conditions and the associated risks that need to be considered as the company develops a deeper
business plan for rolling out, and scaling up RITHMI as a marketable innovative solution. SME Instrument Phase-1 and
Phase-2 will be extremely beneficial in helping the company to accelerate development and market penetration of the
RITHMI solution in target segments, boosting the company’s growth to 40-50 employees and over € 18,395,412 revenues by
2023.